EPILEPSI, vol.23, no.1, pp.13-18, 2017 (ESCI)
Objectives: Levetiracetam (LEV) is an antiepileptic drug approved particularly for treatment of focal seizures. The aim of this study was to investigate efficacy and tolerability of LEV monotherapy in pediatric patients.